![De Li Kong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
De Li Kong
Voorzitter bij
CMIC (Suzhou) Pharmaceutical Technology Co., Ltd.
Health Technology
Profiel
De Li Kong is currently the Chairman of CMIC (Suzhou) Pharmaceutical Technology Co., Ltd. and a Director at Fochon Pharmaceuticals Ltd. Previously, he was a Director at Chongqing Yao Pharmaceutical Co., Ltd.
Actieve functies van De Li Kong
| Bedrijven | Functie | Begin |
|---|---|---|
CMIC (Suzhou) Pharmaceutical Technology Co., Ltd.
 CMIC (Suzhou) Pharmaceutical Technology Co., Ltd. Pharmaceuticals: GenericHealth Technology Manufactures generic pharmaceutical products and drugs | Voorzitter | - |
Fochon Pharmaceuticals Ltd.
 Fochon Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops small molecule drugs | Directeur/Bestuurslid | - |
Eerdere bekende functies van De Li Kong
| Bedrijven | Functie | Einde |
|---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
 Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
CMIC (Suzhou) Pharmaceutical Technology Co., Ltd.
CMIC (Suzhou) Pharmaceutical Technology Co., Ltd. Pharmaceuticals: GenericHealth Technology Manufactures generic pharmaceutical products and drugs | Health Technology |
Fochon Pharmaceuticals Ltd.
Fochon Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops small molecule drugs | Health Technology |
